Autologous anti-CD19 agent produces impressive survival improvements
Interim results of phase 2 trial are promising
Non-home discharge and higher ECOG status associated with IP/IV chemotherapy non-completion
Algorithm reveals many features not appreciated by the unaided eye
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Greater weight means less sleep, lower quality of life
Instrument aids natural orifice endoluminal surgery
First step toward testing therapeutics
Urine prohibitin identified as a prognostic biomarker in Wilms’ tumor
Cleveland Clinic study finds increased detection may not mean higher risk of metachronous advanced neoplasia
Study finds a 43% lower risk of HCC in statin users
Advertisement
Advertisement